Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells: Evidence for an alternate transport system?

Biochemical Pharmacology

Volumn 51, Issue 3, 1996, Pages 301-311

  Parekh, Hemant ^a   Simpkins, Henry ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differences; Human cells; Rodent cells; Taxol cytotoxicity; Transport

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; GLYCOPROTEIN P; MESSENGER RNA; MICROTUBULE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; RADIOISOTOPE; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL LEVEL; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; DRUG SENSITIVITY; DRUG TRANSPORT; HUMAN; HUMAN CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RODENT; SPECIES DIFFERENCE; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL TRANSPORT; CELL SURVIVAL; DRUG RESISTANCE, MULTIPLE; HUMANS; MICROTUBULE PROTEINS; P-GLYCOPROTEIN; PACLITAXEL; RATS; SPECIES SPECIFICITY; TUBULIN; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0030041726     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02176-0     Document Type: Article

References (48)

1. Wani MC, Taylor HL, Wall ME, Coggon P and McPhail AT, Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325-2327, 1971.
2. Rowinsky EK, Onetto N, Canetta RM and Arbuck SG, Taxol: The first of the taxanes, an important new class of antitumor agents. Semin Oncol 19: 646-662, 1992.
3. Rowinsky EK and Donehower RC, The clinical pharmacology of paclitaxel (taxol). Semin Oncol 20: 16-25, 1993.
4. Liebmann JE, Cook JA, Lipshultz C, Teague D, Fisher J and Mitchell JB, Cytotoxic studies of paclitaxel (taxol) in human tumor cell lines. Br J Cancer 68: 1104-1109, 1993.
5. Schiff PB, Fant J and Horwitz SB, Promotion of microtubule assembly in vitro by taxol. Nature 22: 665-667, 1979.
6. Schiff PB and Horwitz SB, Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77: 1561-1565, 1980.
7. Schiff PB and Horwitz SB, Taxol assembles tubulin in the absence of exogenous guanosine 5′-triphosphate or microtubule associated protein. Biochemistry 20: 3247-3252, 1981.
8. Parness J and Horwitz SB, Taxol binds to polymerized tubulin in vitro. J Cell Biol 91: 479-487, 1981.
9. Manfredi JJ, Parness J and Horwitz SB, Taxol binds to cellular microtubules. J Cell Biol 94: 688-696, 1982.
10. Horwitz SB, Mechanism of action of taxol. Trends Pharmacol Sci 13: 134-136, 1992.
11. Rao S, Horwitz SB and Ringel I, Direct photoaffinity labeling of tubulin with taxol. J Natl Cancer Inst 84: 785-788, 1992.
12. Combeau C, Commerçon A, Mioskowski C, Rousseau B, Aubert F and Goeldner M, Predominant labeling of β-over α-tubulin from porcine brain by a photoactivatable taxoid derivative. Biochemistry 33: 6676-6683, 1994.
13. Rao S, Krauss NE, Heerding JM, Swindell CS, Ringel I, Orr GA and Horwitz SB, 3′-(p-Azidobenzamido)taxol photolabels the N-terminal 31 amino acids of β-tubulin. J Biol Chem 269: 3132-3134, 1994.
14. Thompson WC, Wilson L and Purich DL, Taxol induces microtubule assembly at low temperatures. Cell Motil 1: 445-454, 1981.
15. 1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. Cancer Res 54: 4355-4361, 1994.
16. Jordan MA, Toso RJ, Thrower D and Wilson L, Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90: 9552-9556, 1993.
17. Rowinsky EK, Donehower RC, Jones RJ and Tucker RW, Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res 48: 4093-4100, 1988.
18. Lopes NM, Adams EG, Pitts TW and Bhuyan BK, Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol 32: 235-242, 1993.
19. Roberts JR, Allison DC, Donehower RC and Rowinsky EK, Development of polyploidization in taxol-resistant human leukemia cells in vitro. Cancer Res 50: 710-716, 1990.
20. Gottesman MM and Pastan I, Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
21. Bhalla K, Huang Y, Tang C, Self S, Ray S, Mahoney ME, Ponnathpur V, Tourkina E, Ibrado AM, Bullock G and Willingham MC, Characterization of a human myeloid leukemia cell line highly resistant to taxol. Leukemia 8: 465-475, 1994.
22. Keates RAB, Sarangi F and Ling V, Structural and functional alterations in microtubule protein from Chinese hamster ovary cell mutants. Proc Natl Acad Sci USA 78: 5638-5642, 1981.
23. Houghton JA, Houghton PJ, Hazelton BJ and Douglass EC, In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered β-tubulins. Cancer Res 45: 2706-2712, 1985.
24. Cabral F and Barlow SB, Mechanisms by which mammalian cells acquire resistance to drugs that affect microtubule assembly. FASEB J 3: 1593-1599, 1989.
25. Minotti AM, Barlow SB and Cabral F, Resistance to antimitotic drugs in Chinese hamster ovary tumor cells correlates with changes in the level of polymerized tubulin. J Biol Chem 266: 3987-3994, 1991.
26. Debal V, Allam N, Morjani H, Millot JM, Braguer D, Breillout F and Manfait M, Characterisation of a navelbine-resistant bladder carcinoma cell line cross-resistant to taxoids. Br J Cancer 70: 1118-1125, 1994.
27. Ohta S, Nishio K, Kubota N, Ohmori T, Funayama Y, Ohira T, Nakajima H, Adachi M and Saijo N, Characterization of a taxol-resistant human small-cell lung cancer cell line. Jpn J Cancer Res 85: 290-297, 1994.
28. Gupta RS, Species-specific differences in toxicity of antimitotic agents towards cultured mammalian cells. J Natl Cancer Inst 74: 159-164, 1985.
29. Gupta RS, Intrinsic multidrug resistance phenotype of Chinese hamster (rodent) cells in comparison to human cells. Biochem Biophys Res Commun 153: 598-605, 1988.
30. Roy SN and Horwitz SB, A phosphoglycoprotein associated with taxol resistance in J774.2 cells. Cancer Res 45: 3856-3863, 1985.
31. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV and Deeley RG, Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
32. Simpkins H, Lehman JM, Mazurkiewicz JE and Davis BH, A morphological and phenotypic analysis of Walker 256 cells. Cancer Res 51: 1334-1338, 1991.
33. Sklar MD, Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes. Cancer Res 48: 793-797, 1988.
34. Andrews PA, Murphy MP and Howell SB, Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res 45: 6250-6253, 1985.
35. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC and Anderson ME, High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89: 3070-3074, 1992.
36. Al-Shawi MK and Senior AE, Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein. J Biol Chem 268: 4197-4206, 1993.
37. Parekh H and Chitnis M, Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells. Sel Cancer Ther 6: 93-102, 1990.
38. Sambrook J, Fritsch EF and Maniatis T, Extraction, purification, and analysis of messenger RNA from eukaryotic cells. In: Molecular Cloning: A Laboratory Manual (Ed. Nolan C), Vol. 1, pp. 7.3-7.52. Cold Spring Harbor Laboratory Press, Plainview, NY, 1989.
39. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD and Roninson IB, Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160-7164, 1990.
40. Futscher BW, Abbaszadegan MR, Domann F and Dalton WS, Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells. Biochem Pharmacol 47: 1601-1606, 1994.
41. Tiwari SC and Suprenant KA, A pH and temperature-dependent cycling method that doubles the yield of microtubule protein. Anal Biochem 215: 96-103, 1993.
42. Zaman GJR, Versantvoort CHM, Smit JJM, Eijdems EWHM, de Haas M, Smith AJ, Broxterman HJ, Mulder NH, de Vries EGE, Baas F and Borst P, Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53: 1747-1750, 1993.
43. Barrand AB, Heppell-Parton AC, Wright KA, Rabbits PA and Twentymann PRA, A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. J Natl Cancer Inst 86: 110-117, 1994.
44. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC and Deeley RG, Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54: 357-361, 1994.
45. Schneider E, Horton JK, Yang C-H, Nakagawa M and Cowan KH, Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res 54: 152-158, 1994.
46. Schneider E, Cowan KH, Bader H, Toomey S, Schwartz GN, Karp JE, Burke PJ and Kaufmann SH, Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood 85: 186-193, 1995.
47. Jekunen AP, Christen RD, Shalinsky DR and Howell SB, Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro. Br J Cancer 69: 299-306, 1994.
48. Christen RD, Jekunen AP, Jones JA, Thiebaut F, Shalinsky DR and Howell SR, In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules. J Clin Invest 92: 431-440, 1993.